• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸尿症和赖氨酸尿性蛋白不耐受的分子基础。

The molecular bases of cystinuria and lysinuric protein intolerance.

作者信息

Palacín M, Borsani G, Sebastio G

机构信息

Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, E-08028, Barcelona, Spain.

出版信息

Curr Opin Genet Dev. 2001 Jun;11(3):328-35. doi: 10.1016/s0959-437x(00)00198-2.

DOI:10.1016/s0959-437x(00)00198-2
PMID:11377971
Abstract

Cystinuria and lysinuric protein intolerance are inherited aminoacidurias caused by defective amino-acid transport activities linked to a family of heteromeric amino-acid transporters (HATs). HATs comprise two subunits: co-expression of subunits 4F2hc and y(+)LAT-1 induces the efflux of dibasic amino acids from cells, whereas co-expression of subunits rBAT and b(o,+)AT induces the renal reabsorption and intestinal absorption of cystine and dibasic amino acids at the brush border of epithelial cells. Recently, the role of b(o,+)AT (SLC7A9) in cystinuria (non Type I) and the role of y(+)LAT-1 (SLC7A7) in lysinuric protein intolerance have been demonstrated.

摘要

胱氨酸尿症和赖氨酸尿性蛋白不耐受是遗传性氨基酸尿症,由与异源寡聚氨基酸转运蛋白(HATs)家族相关的缺陷性氨基酸转运活性引起。HATs由两个亚基组成:亚基4F2hc和y(+)LAT-1共表达诱导二碱基氨基酸从细胞中流出,而亚基rBAT和b(o,+)AT共表达诱导上皮细胞刷状缘对胱氨酸和二碱基氨基酸的肾重吸收和肠道吸收。最近,已证实b(o,+)AT(SLC7A9)在胱氨酸尿症(非I型)中的作用以及y(+)LAT-1(SLC7A7)在赖氨酸尿性蛋白不耐受中的作用。

相似文献

1
The molecular bases of cystinuria and lysinuric protein intolerance.胱氨酸尿症和赖氨酸尿性蛋白不耐受的分子基础。
Curr Opin Genet Dev. 2001 Jun;11(3):328-35. doi: 10.1016/s0959-437x(00)00198-2.
2
Heteromeric amino acid transporters explain inherited aminoacidurias.异聚氨基酸转运体解释了遗传性氨基酸尿症。
Curr Opin Nephrol Hypertens. 2000 Sep;9(5):547-53. doi: 10.1097/00041552-200009000-00015.
3
Lysinuric protein intolerance: mechanisms of pathophysiology.赖氨酸尿性蛋白不耐受症:病理生理学机制
Mol Genet Metab. 2004 Apr;81 Suppl 1:S27-37. doi: 10.1016/j.ymgme.2003.11.015.
4
The genetics of heteromeric amino acid transporters.异聚氨基酸转运体的遗传学
Physiology (Bethesda). 2005 Apr;20:112-24. doi: 10.1152/physiol.00051.2004.
5
The amino acid transport system b(o,+) and cystinuria.氨基酸转运系统b(o,+)与胱氨酸尿症
Mol Membr Biol. 2001 Jan-Mar;18(1):21-6.
6
Expression of heteromeric amino acid transporters along the murine intestine.异源氨基酸转运体在小鼠肠道中的表达。
J Physiol. 2004 Jul 15;558(Pt 2):597-610. doi: 10.1113/jphysiol.2004.065037. Epub 2004 May 21.
7
The molecular basis of cystinuria: the role of the rBAT gene.胱氨酸尿症的分子基础:rBAT 基因的作用。
Amino Acids. 1996 Jun;11(2):225-46. doi: 10.1007/BF00813862.
8
Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.一种与4F2hc相关联以编码氨基酸转运活性y + L的膜蛋白(y + L氨基酸转运体-1)的鉴定与表征。赖氨酸尿性蛋白不耐受的一个候选基因。
J Biol Chem. 1998 Dec 4;273(49):32437-45. doi: 10.1074/jbc.273.49.32437.
9
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.由编码rBAT亚基(bo,+AT)的SLC7A9基因突变引起的非I型胱氨酸尿症。
Nat Genet. 1999 Sep;23(1):52-7. doi: 10.1038/12652.
10
A new family of proteins (rBAT and 4F2hc) involved in cationic and zwitterionic amino acid transport: a tale of two proteins in search of a transport function.参与阳离子和两性离子氨基酸转运的新蛋白质家族(rBAT和4F2hc):两种寻找转运功能的蛋白质的故事
J Exp Biol. 1994 Nov;196:123-37. doi: 10.1242/jeb.196.1.123.

引用本文的文献

1
The role of double heterozygotes of SLC3A1 and SLC7A9 in the prevalence of cystine stones.SLC3A1和SLC7A9双杂合子在胱氨酸结石患病率中的作用。
Genet Med. 2025 Jan;27(1):101281. doi: 10.1016/j.gim.2024.101281. Epub 2024 Sep 21.
2
Effect of urine alkalization on urinary inflammatory markers in cystinuric patients.尿液碱化对胱氨酸尿症患者尿炎症标志物的影响。
Clin Kidney J. 2024 Feb 22;17(3):sfae040. doi: 10.1093/ckj/sfae040. eCollection 2024 Mar.
3
Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.
氨基酸代谢障碍性疾病——从基础病理生理学到治疗学进展。
Dis Model Mech. 2023 Nov 1;16(11). doi: 10.1242/dmm.050233. Epub 2023 Nov 23.
4
Population genetics analysis of SLC3A1 and SLC7A9 revealed the etiology of cystine stone may be more than what our current genetic knowledge can explain.SLC3A1 和 SLC7A9 的群体遗传学分析表明,胱氨酸结石的病因可能超出了我们目前的遗传知识所能解释的范围。
Urolithiasis. 2023 Aug 10;51(1):101. doi: 10.1007/s00240-023-01473-z.
5
Urinary stone disease in Syrian children.叙利亚儿童的尿路结石病。
Pediatr Nephrol. 2023 Aug;38(8):2699-2709. doi: 10.1007/s00467-022-05860-3. Epub 2023 Jan 20.
6
The Impact of Diet on Urinary Risk Factors for Cystine Stone Formation.饮食对胱氨酸结石形成的尿危险因素的影响。
Nutrients. 2021 Feb 6;13(2):528. doi: 10.3390/nu13020528.
7
Amino Acid Transport Defects in Human Inherited Metabolic Disorders.氨基酸转运缺陷与人类遗传性代谢紊乱
Int J Mol Sci. 2019 Dec 23;21(1):119. doi: 10.3390/ijms21010119.
8
Inducible Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.诱导性敲除小鼠模型重现了赖氨酸尿蛋白不耐受症。
Int J Mol Sci. 2019 Oct 24;20(21):5294. doi: 10.3390/ijms20215294.
9
Mass Spectrometry-based Assay to Identify Drugs that Influence Cystine Solubility.基于质谱分析的方法来鉴定影响胱氨酸溶解度的药物。
Bio Protoc. 2017 Jul 20;7(14). doi: 10.21769/BioProtoc.2417.
10
Amino acid homeostasis and signalling in mammalian cells and organisms.哺乳动物细胞和生物体中的氨基酸稳态与信号传导。
Biochem J. 2017 May 25;474(12):1935-1963. doi: 10.1042/BCJ20160822.